Search Results for: leon.clarke@bezosearthfund.org

In November 2023, as part of ACTA STInG activities, we held an online event that provided valuable insights into seamless Phase 2/3 trial designs in oncology. Among a number of…

This introductory talk focused on distributional cost-effectiveness analysis (DCEA) methods for analysing the health inequality impacts of health programmes and trade-offs with cost-effectiveness. It will be as interactive as possible…

ACTA’s submission to the Senate Inquiry into Australia’s Innovation System was published today. The Inquiry was announced in March 2014 and set to inform a whole-of-Government approach to boosting productivity,…

Writing Clinical Trials Simulators Workshop — Timetable 8:30 am – 12:30 pm, Friday 23rd March Room 1.036, Level 1 HELP Royal Children’s Hospital Parkville, VIC, 3052 The use of simulation is growing…

Clinical Trial 2018: National Tribute and Award Ceremony The Australian Clinical Trials Alliance and the National Health and Medical Research Centre (NHMRC), together with our event partners CT:IQ, MTPConnect, Bellberry…

In May, at ACTA’s Clinical Trials 2018: National Tribute and Awards the Trial of the Year winner was the Australian Placental Transfusion (APT) Trial, the largest ever randomised controlled trial of delayed placental cord-clamping for…

…CTPRG. Next Steps A series of stakeholder consultation workshops will commence in late 2018. This consultation will be open to key organisations and individuals with an interest or working in…

The Victorian Comprehensive Cancer Centre (VCCC) has launched “An Australian-first approach to cancer clinical trials” that it calls registry-based randomised controlled trials or registry trials. The initiative brings together data…

…members who involve consumers (patients and the public) in active partnerships to develop and design collaborative, multicentre, investigator-driven clinical trials. Contact us at awards@clinicaltrialsalliance.org.au for any further information about the awards….

Studies Within A Trial (SWATs): how they can help to make trial process decisions more evidence-based Wednesday, 17 April 2019 5:00 – 6:00pm AEST Professor Shaun Treweek, Health Services Research…

Consumer involvement in research, particularly clinical trials, is growing in Australia. Increasing numbers of consumers – patients and members of the general public – are working with researchers at organisational…

International guest presenter Professor Shaun Treweek joins ACTA online from the University of Aberdeen for this special webinar….

The ACTA International Clinical Trials Conference 2019 brings together Australian and International experts in the cutting-edge design and conduct of clinical trials and registry custodianship, healthcare funding, policy and regulation,…

Designing innovative trials, including Bayesian adaptive trials, was a hot topic at this years’ 2019 ACTA International Clinical Trials Conference in Sydney. We are pleased to announce that a Bayesian…

ACTA welcomes back Adaptive Trial design expert Scott Berry to provide an overview of FDA guidance released for Adaptive Designs for Clinical Trials of Drugs and Biologics. You can download…

OUR VISION Better health through best evidence OUR MISSION AND OBJECTIVES ACTA was established to advance health by: promoting the role of investigator‐initiated clinical trials and clinical quality registries to…

Clinical Trials Networks (CTNs) are collaborative groups of practising clinician-researchers. While some trials are conducted in collaboration with industry, the majority focus on investigator-initiated trials providing unbiased, high-quality scientific evidence…

Access the collection of all available videos here. Cockle Bay Room Thursday 3 October Plenary 1 9:00 – Minister Hunt’s opening address 9:35 – A Clinician’s View—Prof John Zalcberg OAM…

A workshop on Bayesian adaptive randomised trials, delivered by international leaders in this field; Dr Lorenzo Trippa and Dr Steffen Ventz. Update: This event is now sold-out. Please register for…

The number of clinical trials in Australia that are using adaptive methods is increasing.   ACTA Innovative Trial Design Reference Group and ACTA STInG leadership group are heavily involved in…

A clinical program from the Thoracic Oncology Group of Australasia (TOGA), called ‘ASPiRATION’, which aims to assess the impact of personalised healthcare in lung cancer, has been jointly funded by…

…Year ACTA STInG Award for Excellence in Trial Statistics ACTA Consumer Involvement Award Nominations now close on Wednesday 20 May 2020 at 5pm. Please contact awards@clinicaltrialsalliance.org.au with any questions related to nominations….

Given the increased burden that COVID-19 presents across the health sector including clinical trials, the Commission together with the Chair, Professor Chris Brook and the Australian Government Department of Health…

This video, created by Adaptive Health Intelligence, explains the benefits of adaptive trial designs to both researchers and participants….

This video, created by Adaptive Health Intelligence, explains how traditional trials calculate sample size and how adaptive sample sizes work for adaptive trial design….

…Excellence in Trial Statistics ACTA Consumer Involvement Award Update: please note that due to COVID-19, the National Tribute and Award Ceremony was postponed to the ACTA Summit 2020. Please contact awards@clinicaltrialsalliance.org.au with…

ACTA’s Efficient and Effective Clinical Trial Network (CTN) Reference Group has published a document to advise and assist CTNs developing endorsement and trial review guidelines. This document acts as a…

…and capacity for researchers and research organisations to implement involvement activities in clinical trials. Workshop aims: • Raise awareness of the value and contribution consumers and the community can make…

…and capacity for researchers and research organisations to implement involvement activities in clinical trials. Workshop aims: • Raise awareness of the value and contribution consumers and the community can make…

The Australian Clinical Trials Alliance, on behalf investigator-led research sector and informed by the strengthening consumer involvement in clinical trials program, advocates for action to improve clinical research equity (including…